Gomes, L. E. M., Silva, F. A. R. da, Pascoal, L. B., Ricci, R. L., Nogueira, G., Camargo, M. G., Ayrizono, M. de L. S., Fagundes, J. J., & Leal, R. F. (2019). Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics, 74, e1517. https://doi.org/10.6061/clinics/2019/e1517